Navigation Links
AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas
Date:9/19/2013

IRVINE, Calif., Sept. 19, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Chairman and CEO, Thomas W. Gardner, will present a corporate overview at the 2013 Aegis Capital Healthcare Conference. The presentation will take place at 9:00am PT on Saturday, September 28 at The Encore at Wynn in Las Vegas, NV.

In addition to the presentation, Mr. Gardner will be available to meet with analysts, industry executives and investors in one-on-one meetings.  Those interested in meeting with Mr. Gardner during the Conference are encouraged to contact the Company directly at info@atheronova.com.

About AtheroNova

AtheroNova Inc. is a biotechnology company focused on the discovery, research, development and licensing of novel compounds to safely reduce or regress atherosclerotic plaque deposits and improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patented and patents-pending therapies in market sectors that include: Cardiovascular Disease, Stroke, Peripheral Artery Disease, Dementia and Alzheimer's and Erectile Dysfunction, all of which have been linked to atherosclerosis. Atherosclerosis and its related pharmaceutical expenses for these indications cost consumers more than $41 billion annually in the United States alone. For more information, please visit www.AtheroNova.com.

Forward-Looking Statements

This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statemen
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
2. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
3. AtheroNova Announces a New Board Member
4. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
5. AtheroNova Releases 2011 Financial Results
6. AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
7. AtheroNova Names New Director
8. AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
9. AtheroNova Adds New Medical Advisor
10. Noted Atherosclerosis Researcher Joins AtheroNova Team
11. AtheroNova Announces Approval for Phase 1 by the Russian Ministry of Healthcare with Commencement of Human Trials Imminent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... is the device," Nobel laureate Herbert Kroemer famously ... found at the junctures where layers of different ... the interfaces between layers of metal oxides are ... favorites as spintronics, high-temperature superconductors, ferroelectrics and multiferroics. ...
(Date:1/15/2014)... Vernon Hills, IL (PRWEB) January 15, 2014 ... Cole-Parmer to find hard-working items for the lab, from ... designated as Guaranteed-in-Stock (GIS)—ready to ship when you order. ... Masterflex® Peristaltic Pumps , from the L/S® model ...
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... NY (PRWEB) January 15, 2014 The Microcompetition ... a major disease. One of these latent viruses is the ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... theory, a study found that RA patients have high concentrations ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... ... ... in word of mouth (WOM) marketing campaigns for the pharmaceutical and biotechnology industry, announces the ... of Strategic Partnerships. , , , , ,Turner will focus on driving new business and ...
... , ... High Shear Processing Leader Unveils Controlled, Scalable Approach at INTERPHEX 2010 (April 20-22, ... ... NYC), Microfluidics International Corporation (OTCBB: MFLU), the gold standard in pharmaceutical nanomaterials processing, ...
... ... and visualizes existing and promising locations for renewable energy projects. ,The Atlas is the first ... or county and then select from a suite of renewable energy options including biomass, efficiency, ... ...
Cached Biology Technology:HealthTalker Adds Industry Expert Collie Turner to Its Executive Team 2Microfluidics Introduces Revolutionary Bottom-up Technology as a Platform for Continuous Pharmaceutical Manufacturing 2Microfluidics Introduces Revolutionary Bottom-up Technology as a Platform for Continuous Pharmaceutical Manufacturing 3Vermont Launches Renewable Energy Atlas 2Vermont Launches Renewable Energy Atlas 3Vermont Launches Renewable Energy Atlas 4
(Date:7/10/2014)... of enzymes known as heme enzymes, due to the ... At the centre of the heme cofactor is an ... reacting heme is in an intermediate state called Compound ... is whether this oxidation involves just an oxygen atom ... question has implications for understanding oxidative processes within living ...
(Date:7/10/2014)... Operational Environmental Satellite or GOES-West satellite spotted smoke ... raging in Canada,s Northwestern Territories. , At 1200 ... GOES-West captured this image of the brownish-colored haze ... that drifted all the way into South Dakota. ... Project at NASA Goddard Space Flight Center, Greenbelt, ...
(Date:7/10/2014)... used to control everyday household items such as washing ... for conservation, a new study has claimed., As part ... scientists and mathematicians, including those from the University of ... engineering, could be replicated in the natural world to ... ,integral control, - in essence a built-in feedback control ...
Breaking Biology News(10 mins):Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3Feedback control could be key to robust conservation management 2
... scientific breakthrough might assist in the fight against mosquitoes. ... in collaboration with researchers from other universities has chemically ... natural aquatic predators that function as warning signals for ... breeding sites will cause the mosquitoes to sense risk ...
... John Innes Centre have provided a new solution to an old ... parents. In a study to be published online next week in ... found a type of genetic "noise" caused by a surprising degree ... closely related species. They found that when species hybridise, some of ...
... can transmit Lyme disease from host animals to humans, ... when spending time outdoors. University of Illinois ... black-legged ticks (also known as deer ticks), their host ... and Piatt Counties. The survey confirmed the presence ...
Cached Biology News:Mother Nature to provide an environmentally friendly method for reducing mosquitoes 2Mother Nature to provide an environmentally friendly method for reducing mosquitoes 3What causes hybrid vigor? 2Research results confirm need for protection against ticks that carry Lyme disease 2Research results confirm need for protection against ticks that carry Lyme disease 3
... now entered the next frontier of cell-based ... with Cellomics, Inc. The drug discovery process ... Coulter‘s automated solutions systems and Cellomics‘ HCS ... the sub-cellular level. The integration of these ...
... Todays research and biologic production demands on ... to confirming viable cell populations. Therefore, both ... must be determined accurately and precisely. The ... automatic and cost effective means to perform ...
... SureLINK Bioconjugation Kit provides a powerful yet ... and nuceleic acids. The kit provides the ... reagents for quantifying conjugation efficiencies. It enables ... biotin and other tags with a variety ...
... Lumat tube luminometer provides the sensitivity and ... luminometer. Advanced digital photon counting with selected ... of spectral demands. Equipped with up to ... suited for reporter gene assays as well ...
Biology Products: